Innosphere

Company Overview

Snapshot

Founded in May 2016 by Rami Shacour, Ehab Shakour, Gabriel Shakour, and Yousef Badran, Innosphere operates with 1–10 employees. The company has raised $2.5M across two funding rounds. In July 2022, Innosphere secured a grant from the BIRD Foundation.

Business overview

Innosphere is a medical device company focused on developing AI-based brain stimulation treatments for cognitive disorders, specifically ADHD. The company's core technology involves a wearable device that utilizes personalized AF-RNS technology and a unique AI algorithm to optimize treatment efficacy for each patient. Innosphere serves the healthcare market, targeting patients and providers, and operates within the Health Tech & Life Sciences sector, particularly in Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In June 2019, Innosphere's ADHD treatment device garnered significant attention, with high hopes expressed for its potential impact. This indicates early market validation and a positive outlook on the company's innovative approach to addressing cognitive disorders, signaling to investors a promising trajectory in the medical device and digital therapeutics space.

Company Intelligence Q&A

When was Innosphere founded and by whom?

Innosphere was founded in May 2016 by Rami Shacour, Ehab Shakour, Gabriel Shakour, and Yousef Badran.

What is Innosphere's primary focus?

Innosphere develops AI-based brain stimulation devices for the treatment of cognitive disorders, with a primary focus on ADHD.

Has Innosphere received any grants?

Yes, in July 2022, Innosphere secured a grant from the BIRD Foundation.

What is the total capital raised by Innosphere?

Innosphere has raised a total of $2.5M across two funding rounds.

What is the core technology behind Innosphere's treatment?

Innosphere's technology is based on personalized AF-RNS technology and a unique AI algorithm designed to optimize treatment efficacy for each patient.